谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

AK112, a Novel PD-1/VEGF Bispecific Antibody, in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): an Open-Label, Multicenter, Phase II Trial.

Yuanyuan Zhao,Gang Chen,Jianhua Chen, Li Zhuang,Yingying Du,Qitao Yu,Wu Zhuang,Yanqiu Zhao, Ming Zhou,Weidong Zhang,Yu Zhang,Yixin Wan,Wenting Li,Weifeng Song,Zhongmin Maxwell Wang,Baiyong Li,Michelle Xia,Yunpeng Yang,Wenfeng Fang,Yan Huang,Li Zhang

EClinicalMedicine（2023）

引用 0|浏览39
暂无评分
关键词
AK112,Bispecific antibody,Non-small cell lung cancer,PD-1,VEGF,Anti-angiogenesis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要